Plasma 24-metabolite Panel Predicts Preclinical Transition to Clinical Stages of Alzheimer’s Disease

We recently documented plasma lipid dysregulation in preclinical late-onset Alzheimer’s disease (LOAD). A 10 plasma lipid panel, predicted phenoconversion and provided 90% sensitivity and 85% specificity in differentiating an at-risk group from those that would remain cognitively intact. Despite the...

詳細記述

保存先:
書誌詳細
出版年:Front Neurol
主要な著者: Fiandaca, Massimo S., Zhong, Xiaogang, Cheema, Amrita K., Orquiza, Michael H., Chidambaram, Swathi, Tan, Ming T., Gresenz, Carole Roan, FitzGerald, Kevin T., Nalls, Mike A., Singleton, Andrew B., Mapstone, Mark, Federoff, Howard J.
フォーマット: Artigo
言語:Inglês
出版事項: Frontiers Media S.A. 2015
主題:
Neuroscience
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4642213/
https://ncbi.nlm.nih.gov/pubmed/26617567
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2015.00237
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料